COMMUNIQUÉS West-GlobeNewswire

Transpire Bio Achieves Important Corporate Milestone with Completion of First Human Subject Study in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program

17/12/2024 - 14:00

WESTON, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled medicines, today announced that the company has completed the first [...]

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

17/12/2024 - 14:00

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in the Day 74 Letter TNX-102 SL is a non-opioid, centrally acting analgesic, [...]

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761

17/12/2024 - 14:00

Favourable safety profile for world’s first LAG-3 agonist, IMP761, with no treatment related adverse events to date Additional safety data and assessment of PK/PD relationships to follow in first half of CY2025 IMP761 [...]

Avalyn to Present at the 43rd Annual J.P. Morgan Healthcare Conference

17/12/2024 - 14:00

CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. , a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, [...]

Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025

17/12/2024 - 14:05

TAMPA, FL, Dec. 17, 2024 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (the “Company”) (NASDAQ: SCNX), a specialty pharma company with a novel pipeline of brand products, is pleased to announce its participation in The [...]

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

17/12/2024 - 14:08

Cyclerion Has Renegotiated Praliciguat License Agreement to Obtain Upfront and Near-Term Payments as well as Entered into a License Option Agreement for Olinciguat CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- [...]

Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes

17/12/2024 - 14:10

Icovamenib met the primary endpoint, displaying a meaningful statistically significant placebo-corrected mean reduction in HbA1c in the prespecified per protocol patient population Best response achieved in target, beta [...]

Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer

17/12/2024 - 14:28

Statistical Significance Met on Primary Endpoints of 1 Year Survival Rate and Median Overall Survival Doubling of 1 Year Survival Rate and 37% Reduction in Risk of Death Two Month (29%) Increase in Median Overall [...]

December 2024 Letter to Shareholders

17/12/2024 - 14:30

VANCOUVER, Washington, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Dear Shareholders, As I look back on 2024, during which CytoDyn Inc. (“CytoDyn” or the “Company”) achieved multiple crucial milestones, and look forward to 2025 [...]

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

17/12/2024 - 14:30

LAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

17/12/2024 - 14:30

Approval grants Gelteq fast track pathway for drug and entrance into the animal pharmaceuticals space NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and [...]

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

17/12/2024 - 14:30

Company’s Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly EDEN PRAIRIE, Minn., Dec. 17, 2024 (GLOBE NEWSWIRE) -- [...]

TOMI Environmental Solutions Expands Presence in Canadian Market Through Enhanced Partnership with Betatek, Inc.

17/12/2024 - 14:30

FREDERICK, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the expansion [...]

BrightInsight Expands Global Digital Partnership with Sanofi to Build Drug Companion Apps for its Major Specialty Therapies

17/12/2024 - 14:30

Following the success of the MyWay app in the US and Germany, the partners will expand brand-oriented digital health companion apps SAN JOSE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BrightInsight, Inc. today announced [...]

Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its Clinical Advisory Board

17/12/2024 - 14:30

Carlsbad, CA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for [...]

Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference

17/12/2024 - 14:30

BRISBANE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for [...]

Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial

17/12/2024 - 14:37

Patient screening underway; first patient expected to be randomized into the study in January A leading clinical trial site management organization (SMO), Australian Clinical Trial Network (ACTioN), has been engaged to [...]

Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

17/12/2024 - 14:50

Continued progress with both clinical trials of lead program, SON-1010, for solid tumors and Platinum-Resistant Ovarian Cancer (PROC) Executed licensing agreement to support initiation of a Phase 2 clinical trial of SON [...]

Aeroflow Breastpumps Awarded Contract to Provide Breast Pumps to Medicaid Members in Montana

17/12/2024 - 15:00

Aeroflow Breastpumps won the state RFP in Montana to provide mothers under Medicaid with electric breast pumps and other maternal health supplies ASHEVILLE, N.C., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Aeroflow Breastpumps [...]